Hyperinsulinemia, glucose intolerance, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver
J. Clin. Invest. Kazuaki Miyake, et al. 110:1483
doi:10.1172/JCI15880 [Go to this article.]

Problems with a PDF?